SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0000921895-23-000729
Filing Date
2023-03-20
Accepted
2023-03-20 17:04:28
Documents
2

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G sc13g07422ptgx_03202023.htm SC 13G 280972
2 JOINT FILING AGREEMENT ex991to13g07422ptgx_03202023.htm EX-99.1 8413
  Complete submission text file 0000921895-23-000729.txt   291156
Mailing Address 44 MONTGOMERY STREET 40TH FL SAN FRANCISCO CA 94104
Business Address 44 MONTGOMERY STREET 40TH FL SAN FRANCISCO CA 94104 3125066500
BIOTECHNOLOGY VALUE FUND L P (Filed by) CIK: 0000918923 (see all company filings)

IRS No.: 363924731 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G
SIC: 6282 Investment Advice

Mailing Address 7707 GATEWAY BLVD., SUITE 140 NEWARK CA 94560-1160
Business Address 7707 GATEWAY BLVD., SUITE 140 NEWARK CA 94560-1160 (510) 474-0170
Protagonist Therapeutics, Inc (Subject) CIK: 0001377121 (see all company filings)

IRS No.: 980505495 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-89601 | Film No.: 23747053
SIC: 2834 Pharmaceutical Preparations